Equivalent Survival for Sibling and Unrelated Donor Allogeneic Stem Cell Transplantation for Acute Myelogenous Leukemia

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 5, 2007, Pages 601-607

  Moore, John ^a   Nivison Smith, Ian ^b   Goh, Kim ^c   Ma, David ^a   Bradstock, Ken ^d   Szer, Jeff ^e   Durrant, Simon ^f   Schwarer, Anthony ^g   Bardy, Peter ^h   Herrmann, Richard ⁱ   Dodds, Anthony ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b Australasian Bone Marrow Transplant Recipient Registry   (Australia)

^c UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^d WESTMEAD HOSPITAL   (Australia)

^e ROYAL MELBOURNE HOSPITAL   (Australia)

^f ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^g ALFRED HOSPITAL   (Australia)

^h ROYAL ADELAIDE HOSPITAL   (Australia)

ⁱ ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Acute myelogenous leukemia; Hemopoietic stem cell transplantation

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; AUSTRALIA; CANCER RELAPSE; CANCER SURVIVAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; FOLLOW UP; GRAFT VERSUS HOST REACTION; HIGH RISK POPULATION; HLA MATCHING; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MORTALITY; NEUTROPHIL; PATIENT SELECTION; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; REGISTER; RISK FACTOR; SAMPLE SIZE; SIBLING; THROMBOCYTE; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; DISEASE-FREE SURVIVAL; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SIBLINGS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 34247111822     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2007.01.073     Document Type: Article

References (20)

1. Armitage J.O. Bone marrow transplantation. N Engl J Med. 330 (1994) 827-838
2. Nivison-Smith I., Bradstock K.F., Dodds A.J., Hawkins P.A., and Szer J. Haemopoietic stem cell transplantation in Australia and New Zealand, 1992-2001: progress report from the Australasian Bone Marrow Transplant Recipient Registry. Int Med J. 35 (2005) 18-27
3. Burnett A.K., Wheatley K., Goldstone A.H., et al. The value of allogeneic bone marrow transplant in patients with acute myeloid leukaemia at differing risk of relapse: results of the UK MRC AML 10 trial. Br J Haematol. 118 (2002) 385-400
4. Michallet M., Thomas X., Vernant J.P., et al. Long-term outcome after allogeneic hematopoietic stem cell transplantation for advanced stage acute myeloblastic leukemia: a retrospective study of 379 patients reported to the Societe Francaise de Greffe de Moelle (SFGM). Bone Marrow Transplant. 26 (2000) 1157-1163
5. Szydlo R., Goldman J.M., Klein J.P., et al. Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol. 15 (1997) 1767-1777
6. Weisdorf D.J., Anasetti C., Antin J.H., et al. Allogeneic bone marrow transplantation for chronic myelogenous leukemia: comparative analysis of unrelated versus matched sibling donor transplantation. Blood 99 (2002) 1971-1977
7. Flomenberg N., Baxter-Lowe L.A., Confer D., et al. Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood 104 (2004) 1923-1930
8. Keating S., Suciu S., de Witte T., et al., The European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto (GIMEMA) Leukemia Cooperative Groups. Prognostic factors of patients with acute myeloid leukemia (AML) allografted in first complete remission: an analysis of the EORTC-GIMEMA AML 8A trial. Bone Marrow Transplant. 17 (1996) 993-1001
9. Ringden O., Labopin M., Bacigalupo A., et al. Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. J Clin Oncol. 20 (2002) 4655-4664
10. Loberiza F. Summary slides 2003-Part II. IBMTR/ABMTR newsletter Volume 10 2 (2004) 6
11. Greinix H.T., Nachbaur D., Krieger O., et al. Factors affecting long-term outcome after allogeneic haematopoietic stem cell transplantation for acute myelogenous leukaemia: a retrospective study of 172 adult patients reported to the Austrian Stem Cell Transplantation Registry. Br J Haematol. 117 (2002) 914-923
12. Boeckh M., Leisenring W., Riddell S.R., et al. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity. Blood 101 (2003) 407-414
13. Peggs K., and Mackinnon S. Imatinib mesylate-the new gold standard for treatment of chronic myeloid leukemia. N Engl J Med. 348 (2003) 1048-1050
14. Eapen M., Rubinstein P., Zhang M.J., et al. Comparable long-term survival after unrelated and HLA-matched sibling donor hematopoietic stem cell transplantations for acute leukemia in children younger than 18 months. J Clin Oncol. 24 (2006) 145-151
15. Bertz H., Potthoff K., and Finke J. Allogeneic stem-cell transplantation from related and unrelated donors in older patients with myeloid leukemia. J Clin Oncol. 21 (2003) 1480-1484
16. Yakoub-Agha I., Mesnil F., Kuentz M., et al. Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol. 24 (2006) 5695-5702
17. Litzow M.R., Perez W.S., Klein J.P., et al. Comparison of outcome following allogeneic bone marrow transplantation with cyclophosphamide-total body irradiation versus busulphan-cyclophosphamide conditioning regimens for acute myelogenous leukaemia in first remission. Br J Haematol. 119 (2002) 1115-1124 M
18. Nivison-Smith I., Bradstock K.F., Szer J., et al. Allogeneic haemopoietic cell transplants in Australia, 1996-a multi-centre retrospective comparison of the use of peripheral blood stem cells with bone marrow. Bone Marrow Transplant. 28 (2001) 21-27
19. Boeckh M., and Nichols W.G. The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy. Blood 103 (2003) 2003-2008
20. Craddock C., Szydlo R.M., Dazzi F., et al. Cytomegalovirus seropositivity adversely influences outcome after T-depleted unrelated donor transplant in patients with chronic myeloid leukaemia: the case for tailored graft-versus-host disease prophylaxis. Br J Haematol. 112 (2001) 228-236